Cytokine Interleukin 17 May Be Treatment Target For Patients With Lung Cancer Who Are Also Infected With SARS-CoV-2, Study Suggests

Infectious Disease Advisor (5/12, Bennett) reports researchers concluded that “the cytokine interleukin 17 (IL-17) may be a possible therapeutic target worth investigating for patients with lung cancer who are simultaneously infected with SARS-CoV-2.” The...